Alyeska Investment Group’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-4,501
| Closed | -$6.48M | – | 365 |
|
|
2018
Q3 | $6.48M | Sell |
4,501
-90
| -2% | -$130K | 0.07% | 206 |
|
|
2018
Q2 | $7.41M | Sell |
4,591
-279
| -6% | -$450K | 0.07% | 232 |
|
|
2018
Q1 | $7.9M | Buy |
4,870
+3,242
| +199% | +$5.26M | 0.07% | 233 |
|
|
2017
Q4 | $2.73M | Sell |
1,628
-1,962
| -55% | -$3.29M | 0.02% | 283 |
|
|
2017
Q3 | $5.02M | Buy |
3,590
+90
| +3% | +$126K | 0.04% | 275 |
|
|
2017
Q2 | $3.91M | Buy |
+3,500
| New | +$3.91M | 0.03% | 282 |
|
|
2015
Q4 | – | Sell |
-350
| Closed | -$196K | – | 401 |
|
|
2015
Q3 | $196K | Buy |
350
+32
| +10% | +$17.9K | ﹤0.01% | 439 |
|
|
2015
Q2 | $253K | Buy |
318
+5
| +2% | +$3.98K | ﹤0.01% | 448 |
|
|
2015
Q1 | $261K | Buy |
313
+23
| +8% | +$19.2K | ﹤0.01% | 454 |
|
|
2014
Q4 | $209K | Sell |
290
-11
| -4% | -$7.93K | ﹤0.01% | 444 |
|
|
2014
Q3 | $209K | Sell |
301
-4
| -1% | -$2.78K | ﹤0.01% | 350 |
|
|
2014
Q2 | $257K | Sell |
305
-447
| -59% | -$377K | 0.01% | 348 |
|
|
2014
Q1 | $1.23M | Buy |
+752
| New | +$1.23M | 0.03% | 238 |
|